Literature DB >> 28450048

Liraglutide alleviates H2O2-induced retinal ganglion cells injury by inhibiting autophagy through mitochondrial pathways.

Xuefei Ma1, Wenjian Lin1, Zhenyu Lin1, Ming Hao1, Xinyuan Gao1, Yue Zhang1, Hongyu Kuang2.   

Abstract

Retinal ganglion cells (RGCs), which exist in the inner retina, are the retinal neurons which can be damaged in the early stage of diabetic retinopathy (DR). Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, exerts biological functions by binding the receptor (GLP-1R), the expression of which in RGC-5 cells was first shown by our team in 2012. It was reported that liraglutide prevented retinal neurodegeneration in diabetic subjects. However, the involvement of mechanisms such as autophagy and mitochondrial balance in liraglutide-induced retinal protection is unknown. Here, we aimed to investigate the protective effects of liraglutide and explore the potential mechanisms of liraglutide-induced retinal RGC protection. RGC-5 cells were treated with H2O2 and/or liraglutide. Cell viability was detected with the CCK-8 kit. The axon marker GAP43, autophagy and mitophagy indicators LC3A/B, Beclin-1, p62, Parkin, BCL2/Adenovirus E1B 19kDa protein-interacting protein 3-like (BNIP3L) and the key regulator of mitochondrial biogenesis PGC-1α were examined via western blot analysis. Autophagy was also evaluated using the ImageXpress Micro XLS system and transmission electron microscopy (TEM). Reactive oxygen species (ROS), mitochondrial membrane potential and fluorescent staining for mitochondria were also measured using the ImageXpress Micro XLS system. Our results showed that pretreatment with liraglutide significantly prevented H2O2-induced cell viability decline, mitochondrial morphological deterioration and induction of autophagy, which appeared as increased expression of LC3 II/I and Beclin-1, along with p62 degradation. Moreover, liraglutide suppressed the H2O2-induced decline in GAP43 expression, thus protecting cells. However, rapamycin induced autophagy and blocked the protective process. Liraglutide also provided mitochondrial protection and appeared to alleviate H2O2-induced ROS overproduction and a decline in mitochondrial membrane potential, partially by promoting mitochondrial generation and attenuating mitophagy. In conclusion, liraglutide attenuates H2O2 induced RGC-5 cell injury by inhibiting autophagy through maintaining a balance between mitochondrial biogenesis and mitophagy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Liraglutide; Mitochondrial biogenesis; Mitophagy; Retinal ganglion cells

Mesh:

Substances:

Year:  2017        PMID: 28450048     DOI: 10.1016/j.peptides.2017.04.008

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Cardiovascular effects of antiobesity drugs: are the new medicines all the same?

Authors:  Mauro Cataldi; Angelo Cignarelli; Francesco Giallauria; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

2.  Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells.

Authors:  Theodora Panagaki; Maria Michael; Christian Hölscher
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 3.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

4.  Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.

Authors:  M Angelyn Bethel; Robert J Mentz; Peter Merrill; John B Buse; Juliana C Chan; Shaun G Goodman; Nayyar Iqbal; Neli Jakuboniene; Brian Katona; Yuliya Lokhnygina; Renato D Lopes; Aldo P Maggioni; Peter Ohman; Tsvetalina Tankova; George L Bakris; Adrian F Hernandez; Rury R Holman
Journal:  Diabetes Care       Date:  2019-11-22       Impact factor: 19.112

5.  Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Authors:  Menaka C Thounaojam; Folami L Powell; Sagar Patel; Diana R Gutsaeva; Amany Tawfik; Sylvia B Smith; Julian Nussbaum; Norman L Block; Pamela M Martin; Andrew V Schally; Manuela Bartoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 12.779

Review 6.  Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy.

Authors:  Qiaoyun Gong; Haiyan Wang; Ping Yu; Tianwei Qian; Xun Xu
Journal:  Front Med (Lausanne)       Date:  2021-03-25

Review 7.  Autophagy and Diabetic Encephalopathy: Mechanistic Insights and Potential Therapeutic Implications.

Authors:  Li-Zhen Cheng; Wei Li; Yi-Xin Chen; Yi-Jia Lin; Ya Miao
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

8.  Management of mitochondrial diabetes in the era of novel therapies.

Authors:  Roseanne O Yeung; Mohammad Al Jundi; Sriram Gubbi; Maria E Bompu; Sandra Sirrs; Mark Tarnopolsky; Fady Hannah-Shmouni
Journal:  J Diabetes Complications       Date:  2020-04-13       Impact factor: 2.852

9.  Liraglutide Protects Against Brain Amyloid-β1-42 Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation.

Authors:  Ana I Duarte; Emanuel Candeias; Inês N Alves; Débora Mena; Daniela F Silva; Nuno J Machado; Elisa J Campos; Maria S Santos; Catarina R Oliveira; Paula I Moreira
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

10.  Resveratrol acts via the mitogen-activated protein kinase (MAPK) pathway to protect retinal ganglion cells from apoptosis induced by hydrogen peroxide.

Authors:  Ming-Jing Ye; Ni Meng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.